CLCN5 and chronic kidney disease: Citrates are also given to improve acidosis, and to slow the progression of CKD (Lieske et al. 1993; Zaniew et al. 2017), given the positive results obtained in Clcn5 KO mice (Cebotaru et al. 2005).